Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nova Leap Health Corp. (NLH.V)
Halifax, NS, CA
Nova Leap Health Corp. delivers a comprehensive array of in-home and healthcare-at-home solutions across the United States and Canada. Their offerings encompass specialized dementia support, social companionship, assistance with personal needs, and temporary relief for family caregivers. They additionally manage household tasks such as cooking, meal preparation, cleaning, running errands, and providing transportation. Crucially, qualified nursing personnel provide medication reminders. Established in 2015, Nova Leap Health Corp. maintains its primary operations base in Halifax, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +12.50% | +12.50% | +28.57% | +44.00% | +100.00% | -52.00% | +176.92% | +176.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+24.3% ★ Q1'26: +8.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-114.0% Q1'26: +470.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+4.3% Q1'26: +4.6% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+3.5% Q1'26: +3.7% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+5.5% Q1'26: +4.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.2% ★ Q1'26: +0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.48× ★ Q1'26: 1.63× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
17.31M
est: 17.38M (-0.4%)
|
21.28M
est: 21.41M (-0.6%)
|
28.21M
est: 28.14M (+0.2%)
|
26.18M
est: 18.92M (+38.3%)
|
25.76M
est: 25.79M (-0.1%)
|
32.02M
est: 32.02M (+0.0%)
|
| EBITDA |
2.36M
est: 1.77M (+33.1%)
|
4.76M
est: 2.18M (+117.8%)
|
420.4K
est: 2.87M (-85.3%)
|
994.5K
est: 1.65M (-39.6%)
|
2.50M
est: 2.24M (+11.5%)
|
1.97M
est: 2.79M (-29.2%)
|
| EBIT |
573.7K
est: 1.21M (-52.4%)
|
2.87M
est: 1.48M (+93.6%)
|
-935.6K
est: 1.95M (-147.9%)
|
460.2K
est: 1.05M (-56.1%)
|
1.92M
est: 1.43M (+34.3%)
|
1.13M
est: 1.77M (-36.6%)
|
| Net Income |
1.26M
est: -174.8K (+818.5%)
|
1.76M
est: 1.73M (+1.9%)
|
-835.7K
est: 1.73M (-148.3%)
|
-1.05M
|
1.38M
est: 843.2K (+63.5%)
|
-193.2K
|
| SGA |
5.72M
est: 5.84M (-2.0%)
|
7.58M
est: 7.19M (+5.4%)
|
9.68M
est: 9.45M (+2.4%)
|
8.42M
est: 6.37M (+32.2%)
|
8.44M
est: 8.68M (-2.8%)
|
10.73M
est: 10.78M (-0.5%)
|
| EPS |
0.02
est: 0.00 (+1,101.2%)
|
0.02
est: 0.02 (+1.3%)
|
-0.01
est: 0.02 (-154.6%)
|
-0.01
|
0.02
est: 0.01 (+62.6%)
|
0.00
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Christopher Donald Dobbin | Chief Executive Officer, President & Director | 385.0K | male |
| Melissa Anderson | Senior President of Operations (U.S.) | 263.7K | female |
| Chris LeBlanc | Company Secretary & Chief Financial Officer | 240.0K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NLH.V
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
